Assuring Adequate Treatment for Persons Diagnosed With Gonorrhea in New York State
- PMID: 33045162
- DOI: 10.1097/OLQ.0000000000001241
Assuring Adequate Treatment for Persons Diagnosed With Gonorrhea in New York State
Abstract
Background: From November 2014 to May 2016, 57 local health departments in New York State (NYS) excluding New York City were offered a performance incentive (PI) to promote adherence to federally recommended treatment guidelines for gonorrhea. The rationale of the PI was to delay antibiotic resistance and disrupt transmission through attaining a high percentage of treatment adherence.
Methods: Surveillance data from the NYS Communicable Disease Electronic Surveillance System were used for analysis. We evaluated adherence per Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines for persons 12 years and older reported with uncomplicated gonorrhea during 4 time frames: Pre-PI, PI One, PI Two, and Post-PI. We measured adherence per the Centers for Disease Control and Prevention sexually transmitted disease treatment guidelines during each respective time frame and conducted χ tests to test for the association between treatment adequacy and time frame.
Results: During the Pre-PI, treatment was adequate in 82.0% of persons diagnosed with gonorrhea. After program implementation, treatment adequacy increased significantly (92.1% of diagnosed persons during PI One, 90.4% during PI Two, and 90.5% during the Post-PI; P ≤ 0.0001). The most common reason for inadequate or missing treatment was patient lost to follow-up.
Conclusions: Public health intervention by the NYS Department of Health improved local health department adherence to federally recommended gonorrhea treatment guidelines, and improvements were maintained after the completion of the PI.
References
-
- Braxton J, Davis DW, Emerson B, et al. Centers for Disease Control and Prevention sexually transmitted disease surveillance 2017. HIV AIDS Surveill Rep 2018.
-
- Wi T, Lahra M, Ndowa F, et al. Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action. PLoS Med 2017; 14:e1002344.
-
- Deguchi T, Nakane K, Yasuda M, et al. Emergence and spread of drug resistant Neisseria gonorrhoeae. J Urol 2010; 184:851–858.
-
- Chesson HW, Kirkcaldy RD, Gift TL, et al. An illustration of the potential health and economic benefits of combating antibiotic-resistant gonorrhea. Sex Transm Dis 2018; 45:250.
-
- Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2006. MMWR Recomm Rep 2006; 55:2–49.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
